We are pleased to present the scope of the journal...
With a 2009 impact factor of 6.993 and 95% of accepted articles publishing online in less than 25 business days, NPP had more than 60,000 linkouts to articles in PubMed in the first quarter of 2008. It ranks 6/117 in Psychiatry journals, 10/236 in Pharmacology and Pharmacy journals, and 18/230 in Neuroscience journals.
Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behaviour, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.
In view of the interdisciplinary nature of the field, particular emphasis is placed on:
studies that advance the biological bases of normal and pathological behavior
the nature, etiology and pathophysiology of neuropsychiatric disorders
biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
the basic mechanisms by which psychopharmacological agents exert their effect
Dr James H Meador-Woodruff, MD
Editor-in-Chief
Deputy Editors Associate Editors Editorial Board
Instructions for Authors:
- Submission (includes registering for an account, formatting, and process)
- Editorial Policy (includes Disclosure Policy and Conflict of Interest forms)
Instructions for Reviewers: